Tag archive for ‘CBI’
Vered Weiss On Sunday, January 25th, 2015

Gary Cohn of Goldman Sachs Urges UK Not to Leave the EU

Leaving the European Union would be a bad idea for England, particularly its financial sector, Goldman Sach’s Chief Operating Officer Gary Cohn told the BBC. Cohn said Goldman Sachs prefers to operate More...

Jewish Business News On Thursday, January 22nd, 2015

D-Pharm Raises $3 Million

Israel’s biomedical firm D-Pharm Ltd announced the successful completion of fundraising via a public rights issue, of 12.8 million NIS ($3.2 million) in aggregate. D-Pharm’s largest shareholder,  More...

Reuters On Tuesday, November 18th, 2014

Exclusive: Iran uses China bank to transfer funds to Quds-linked companies – report

–   There is no trace of Shenzhen Lanhao Days Electronic Technology Co Ltd at its listed address in the beige and pink-tiled “Fragrant Villa” apartment complex in this southern Chinese More...

Gil Tanenbaum On Monday, October 27th, 2014

Clal Biotech Sells Pidilizumab Cancer Treatment Rights to Medivation

Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are held by Clal subsidiary More...

Globes On Tuesday, September 23rd, 2014

Clal Biotech Suing Hyperion for $200 Million over ‘Rash and Ill Considered’ Andromeda Decisions

Clal Biotechnology Industries Ltd. (TASE: CBI announced yesterday that it had filed a $200 million suit against drug company Hyperion Therapeutics Inc. (Nasdaq: HPTX) in the US in the State of Delaware Court, More...

ANDROMADA
Jewish Business News On Monday, September 22nd, 2014

Clal Biotech: No Evidence of Misconduct by Us

Clal Biotechnology Industries Ltd. (TASE: CBI) notified the Tel Aviv Stock Exchange this morning that it had contacted Hyperion Therapeutics Inc. (Nasdaq: HPTX) as part of its efforts to gather as much information More...

Gali Weinreb On Monday, February 3rd, 2014

More Israeli Life Sciences Companies Going To Nasdaq

– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation.  – In the coming weeks, several Israeli life sciences companies will examine whether More...

Wordpress site Developed by Fixing WordPress Problems